Clinical trials
Phase 3 Urinary Bladder Neoplasms trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2008 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 7 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 5 |
| AstraZeneca | 3 |
| Bristol-Myers Squibb | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Medical Enterprises Europe B.V. | 1 |
| Pfizer | 1 |
| Sanofi | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 20 |
| Carcinoma, Transitional Cell | 5 |
| Neoplasms | 2 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Urethral Neoplasms | 2 |
| Urologic Neoplasms | 2 |
| Hyperthermia | 1 |
| Neoplasms by Site | 1 |
| Urinary Bladder Diseases | 1 |
| Urologic Diseases | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.